cancer and inflamation

Upload: astirindarwati1745

Post on 02-Jun-2018

224 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Cancer and Inflamation

    1/49

    Inflammation and Cancer

    Pin Ling (), Ph.D.

    ext 5632; [email protected]

    References:

    1. Hallmarks of Cancer: The Next Generation (Cell,

    2011)2. Paradoxical roles of immune system during cancer

    development (Nat Rev. Cancer, 2006)

    3. Insight Review on Inflammation (Nature, 2008, July)

  • 8/10/2019 Cancer and Inflamation

    2/49

    Outline

    1. Roles of the immune system in cancerdevelopment

    2. Overview of Inflammation

    3. Inflammation, The NF-kB pathway, and CancerDevelopment

    4. Tumor microenvironment and Tumor-AssociatedMacrophages

  • 8/10/2019 Cancer and Inflamation

    3/49

    Cancer development & Microenvironment

    1. Cancers are not only autonomous masses of mutant cells.=> Composed of other cell types?

    => fibroblasts, epithelial cells, immune cells,cellsforming blood & lymphatic vessels, & mesenchymal cells.

    2. Tissue homeostasisis maintained by coordinatedinteractions between these diverse cell types.

    => How about cancer?

    => Cancerous cells hijack the normal physiological

    process to favour their own survival.

    3. Most cancers found in clinical are already the outcomeof hijacking microenvironmentby malignant cells

    Here we focus on the relationship betweenthe immune cells and cancers.

  • 8/10/2019 Cancer and Inflamation

    4/49

    Paradoxical roles of the immunesystem in cancer development

    1. The key functions of the mammalian immune system:(1) Protect from infectious pathogens(2) Monitor tissue homeostasis => Eliminate damaged

    cells or tumor cells

    2. Mechanisms against cancer development:(1) Cellular immunity- T, NK, & Other innate immune cells(2) Humoral immunity- Cytokines, Abs, ..etc

    3. Mechanisms promoting cancer development:(1) Inflammation => Angiogenesis & Tissue remodelling(2) Enhance survival pathways (NF-kB)(3) Suppression of anti-tumor immune responses

  • 8/10/2019 Cancer and Inflamation

    5/49

    Cancers display the signs of inflammation-infiltration of immune cells

    HE Stain

    CD45 Stain

    (all immune cells)

    Most cancers outplay the immune system

    => Escape from cytotoxic T cell attacks

    => Make other immune cells help their survival

  • 8/10/2019 Cancer and Inflamation

    6/49

    The complex relationship betweenthe immune system and cancers-I

    1. Adaptive and innate immune cells regulate tissuehomeostasis and efficient wound healing

    2. Altered interactions between adaptive and innate immune

    cells can lead to chronic inflammatory disorders.

    3. Chronic inflammatory conditions enhance a predisposition tocancer development.

    4. In cancers, an abundance of infiltrating innate immune cells(e.g. macrophages, mast cells, and neutrophils)correlateswith increased angiogenesis and/or poor prognosis.

  • 8/10/2019 Cancer and Inflamation

    7/49

    The complex relationship betweenthe immune system and cancers-II

    5. Long-term usage of non-steroidal anti-inflammatory drugsand selective cyclooxygenase 2 (COX2) inhibitors reducescancer incidence.

    6. In cancers, an abundance of infiltrating lymphocytescorrelates with favourable prognosis.

    7. Activation of anti-tumour adaptive immune responses cansuppress tumour growth

    8. Polymorphisms in genes that regulate immune balanceinfluence cancer risk.

    9. Genetic elimination or depletion of immune cells alters

    cancer progression in experimental models.

  • 8/10/2019 Cancer and Inflamation

    8/49

    Outline

    1. Roles of the immune system in cancerdevelopment

    2. Overview of Inflammation

    3. Inflammation, The NF-kB pathway, and CancerDevelopment

    4. Tumor microenvironment and Tumor-AssociatedMacrophages

  • 8/10/2019 Cancer and Inflamation

    9/49

    Causes & Outcomes of Inflammation

  • 8/10/2019 Cancer and Inflamation

    10/49

    The Inflammatory Pathway

  • 8/10/2019 Cancer and Inflamation

    11/49

    Inflammation in innate and adaptiveimmunity

    Inflammatory cells, cytokines, & chemokines

    are major effectors in this process.

  • 8/10/2019 Cancer and Inflamation

    12/49

    PRRs for sensing infectious &endogenous stimuli

    1. PRRs (PatternRecognition Receptor) for:

    (1) PAMPs from pathogens(2) DAMPs (DangerAssociated Molecular

    Patterns)from host cells

    2. Deregulated immuneresponses to these stimulileading to

    Infectious diseases Autoimmune disorders Allergy

    Cancer development

  • 8/10/2019 Cancer and Inflamation

    13/49

    An infection case of inflammation

  • 8/10/2019 Cancer and Inflamation

    14/49

    Macrophages release cytokines andinitiate an inflammation response

    during infection

  • 8/10/2019 Cancer and Inflamation

    15/49

    Leukocytes transmigrate to infectionsites

  • 8/10/2019 Cancer and Inflamation

    16/49

    Trafficking molecules in the multi-stepadhesion cascade

  • 8/10/2019 Cancer and Inflamation

    17/49

    An overview of leukocyte migration atsites of inflammation

  • 8/10/2019 Cancer and Inflamation

    18/49

    Inflammatory cytokines secretedby macrophages

    (IL-8)

  • 8/10/2019 Cancer and Inflamation

    19/49

    Resolution of acute inflammation

    Lipid mediator class switching:

    PGE2, Leukotrienes => Lipoxins

  • 8/10/2019 Cancer and Inflamation

    20/49

    Lipid mediators in Pro- & Anti-inflammatory responses

  • 8/10/2019 Cancer and Inflamation

    21/49

    Role of macrophages in resolutionof inflammation

  • 8/10/2019 Cancer and Inflamation

    22/49

    Key Concepts about Inflammation-I

    1. Inflammation- A physiological process whereby tissuesrespond to infectious & non-infectious insults(alsocalled sterile inflammation, including toxic, traumatic, orautoimmune insults).

    2. Four key signs:(1) Redness (2)Swelling (3) Heat (4)Pain

    3. This process includes several phases:

    (1) Initial phase-Changes in local blood flow &accumulation of inflammatory cells (neutrophiles,macrophages, DCs, & lymphocytes)

    (2) Middle phase-Resolution of initial insults

    (3) Final phase-Termination of inflammation & tissue

    repair

  • 8/10/2019 Cancer and Inflamation

    23/49

    Key Concepts about Inflammation-II

    4. Dysregulation of any step in the inflammationprocess leads to diseases.

    5. While acute inflammation is a part of the defense

    response, chronic inflammation leads toinflammatory disorders, diabetes, atherosclerosis,& Cancer.

    6. Malignant cells actively turn the inflammationprocess to become the chronic status.

    7. Chronic inflammation creates a microenvironmentfor cancer progression.

  • 8/10/2019 Cancer and Inflamation

    24/49

    Outline

    1. Roles of the immune system in cancerdevelopment

    2. Overview of Inflammation

    3. Inflammation, The NF-kB pathway, and CancerDevelopment

    4. Tumor microenvironment and Tumor-AssociatedMacrophages

  • 8/10/2019 Cancer and Inflamation

    25/49

    Question

    Q: Whether all the inflammation is

    the same?

  • 8/10/2019 Cancer and Inflamation

    26/49

    Role of chronic inflammation inpromoting cancer development

  • 8/10/2019 Cancer and Inflamation

    27/49

    Pathways connecting inflammation &cancers

  • 8/10/2019 Cancer and Inflamation

    28/49

    Oncogenes & Cancer-relatedInflammation

  • 8/10/2019 Cancer and Inflamation

    29/49

    Hallmarks of Cancer-2000

    Inflammation

    Inflammation

    Inflammation

  • 8/10/2019 Cancer and Inflamation

    30/49

    Inflammation is the 7thhallmark of cancer

    Mantovani, A., Nature, 20091

  • 8/10/2019 Cancer and Inflamation

    31/49

    Hallmarks of Cancer-2011

    Hanahan, D. & Weunberg, RA, Cell , 2011

  • 8/10/2019 Cancer and Inflamation

    32/49

    Inflammatory network in cancer

    The NF-kB pathway is the key underlyingpathway promoting cancer

  • 8/10/2019 Cancer and Inflamation

    33/49

    The NF-kB

    Pathway

    1. Inflammation

    2. Innate immuneresponses

    3. Survival

    F k d k

  • 8/10/2019 Cancer and Inflamation

    34/49

    NF-kB induces cytokines to promotetumor survival

  • 8/10/2019 Cancer and Inflamation

    35/49

    Association of inflammation with cancers

  • 8/10/2019 Cancer and Inflamation

    36/49

    Outline

    1. Roles of the immune system in cancerdevelopment

    2. Overview of Inflammation

    3. Inflammation, The NF-kB pathway, and CancerDevelopment

    4. Tumor microenvironment and Tumor-AssociatedMacrophages

  • 8/10/2019 Cancer and Inflamation

    37/49

  • 8/10/2019 Cancer and Inflamation

    38/49

    Signaling Network in the TumorMicroenvironment

    A d l f i t & d ti i

  • 8/10/2019 Cancer and Inflamation

    39/49

    A model of innate & adaptive immunecells in cancer development

  • 8/10/2019 Cancer and Inflamation

    40/49

    Cancer cell

    necrosispromotes tumorprogression byrecruitingmacrophages

    M h l i ti d i t

  • 8/10/2019 Cancer and Inflamation

    41/49

    Macrophage polarization during tumorprogression

  • 8/10/2019 Cancer and Inflamation

    42/49

    d h

  • 8/10/2019 Cancer and Inflamation

    43/49

    Tumor-associated macrophages inpromoting cancer

  • 8/10/2019 Cancer and Inflamation

    44/49

    Hanahan, D. & Weunberg, RA, Cell , 2011

    Targeting of Hallmarks of Cancer

  • 8/10/2019 Cancer and Inflamation

    45/49

    The End & Thank You

    Figure 1

  • 8/10/2019 Cancer and Inflamation

    46/49

    Source: Cell , Volume 144, Issue 5, Pages 646-674(DOI:10.1016/j.cell.2011.02.013)

    Copyright 2011 Elsevier Inc. Terms and Conditions

    Li id di t i P & A ti

    http://www.cell.com/abstract/S0092-8674(11)00127-9http://www.cell.com/cellpress/TermsandConditionshttp://www.cell.com/cellpress/TermsandConditionshttp://www.cell.com/abstract/S0092-8674(11)00127-9http://www.cell.com/abstract/S0092-8674(11)00127-9http://www.cell.com/abstract/S0092-8674(11)00127-9
  • 8/10/2019 Cancer and Inflamation

    47/49

    Lipid mediators in Pro- & Anti-inflammatory responses

  • 8/10/2019 Cancer and Inflamation

    48/49

  • 8/10/2019 Cancer and Inflamation

    49/49